Prostate cancer is the most common malignant disease in men in the Western world. Improved diagnostics and an increased life expectancy have led to a significant rise in the number of annual new cases in Germany.
The prostate-specific antigen (PSA) is a widely used diagnostic tool for prostate cancer. While it offers the advantage of early predictive capability, it also has limitations, particularly in terms of specificity. This book discusses the strengths and weaknesses of PSA in detail.
Multi-variable analysis and the use of new biomarkers in blood and urine are promising approaches to improve diagnostics. This book explores these possibilities and discusses the potential benefits and challenges associated with these methods.
Several tissue markers play a crucial role in the diagnosis and prognosis of prostate cancer. This book examines these markers and the advances in prostate imaging, providing insights into the current state of diagnostic capabilities.
This book offers a compact overview of the comprehensive topic of prostate cancer diagnostics, incorporating the latest research findings. It is an essential resource for healthcare professionals and researchers seeking to understand the current landscape of prostate cancer diagnosis.
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline